**Cymbalta Recall: Antidepressant Contaminated With Chemical**

muazhan

You need 3 min read

·

Post on Oct 24, 2024

63 visitor like this post

Share

Cymbalta Recall: Antidepressant Contaminated with Chemical

A recent recall of the popular antidepressant Cymbalta (duloxetine) has raised concerns among patients and healthcare professionals. The recall, initiated by manufacturer Eli Lilly, stems from the discovery of a potential contaminant in some batches of the medication.

What is Cymbalta?

Cymbalta is a prescription medication used to treat a variety of conditions, including:

• Major Depressive Disorder (MDD)
• Generalized Anxiety Disorder (GAD)
• Diabetic Peripheral Neuropathic Pain
• Fibromyalgia
• Chronic Musculoskeletal Pain

It works by increasing levels of serotonin and norepinephrine, neurotransmitters that play a role in mood regulation and pain perception.

The Recall: What is the Issue?

The recall was prompted by the detection of a potential contaminant in some batches of Cymbalta. The contaminant, N-nitroso-duloxetine, is classified as a "probable human carcinogen" by the International Agency for Research on Cancer (IARC).

While the presence of the contaminant is below the acceptable daily intake limit set by the European Medicines Agency (EMA), Eli Lilly opted to issue a voluntary recall out of an abundance of caution.

Who is Affected by the Recall?

The recall affects specific batches of Cymbalta capsules with the following information:

• Product: Cymbalta (duloxetine) capsules
• NDC: 0007-0071-10, 0007-0071-20, 0007-0071-30
• Expiration Dates: All lots with expiration dates between October 2024 and January 2026

If you have Cymbalta capsules matching the information above, you should stop taking the medication and contact your healthcare provider or pharmacist.

What Should I Do if I Have Taken Recalled Cymbalta?

If you have taken Cymbalta from a recalled batch, it's important to speak with your doctor. They can advise you on the best course of action, which may include:

• Monitoring for potential side effects: While the contaminant is below the acceptable daily intake limit, it's still possible to experience some side effects.
• Adjusting your medication: Your doctor may recommend switching to a different antidepressant or adjusting your dose.
• Providing information: Your doctor may need to collect information about your experience to contribute to ongoing research.

What are the Potential Risks of N-nitroso-duloxetine?

While the presence of N-nitroso-duloxetine in the recalled Cymbalta batches is below the acceptable daily intake limit, long-term exposure to the contaminant has been linked to an increased risk of cancer.

It's important to note that this risk is based on animal studies and the actual risk to humans is unknown.

What are the Alternatives to Cymbalta?

If you're currently taking Cymbalta and are concerned about the recall, you may need to consider alternative treatments.

It's important to discuss your options with your healthcare provider as they can determine the best course of action for you based on your individual needs and health history.

Key Takeaways:

• Eli Lilly has recalled specific batches of Cymbalta due to the presence of a potential contaminant, N-nitroso-duloxetine.
• While the contaminant level is below the acceptable daily intake limit, it's classified as a probable human carcinogen.
• The recall affects Cymbalta capsules with specific NDC numbers and expiration dates.
• If you have recalled Cymbalta, stop taking it and contact your healthcare provider.
• Your doctor can advise you on alternative treatment options.

This article is for informational purposes only and should not be considered medical advice. Always consult with your healthcare provider for any health concerns or before making any decisions related to your treatment.